Correction to: Sequential Treatment of Sorafenib-Regorafenib Versus Sorafenib-Physician's Choice: A Propensity Score-Matched Analysis.
Bang Y, Yoo C, Lonardi S, Kim HD, Vivaldi C, Rimini M, Frassineti GL, Park SR, Rizzato MD, Ryu MH, Salani F, Rapposelli IG, Ryoo BY, Zagonel V, Massa V, Valgiusti M, Burgio V, Scartozzi M, Cascinu S, Casadei-Gardini A.
Bang Y, et al. Among authors: park sr.
Target Oncol. 2021 May;16(3):411-412. doi: 10.1007/s11523-021-00808-3.
Target Oncol. 2021.
PMID: 33738697
No abstract available.